AGP Executive Report
Last update: 9 hours agoPublic Health Alert (Ebola): Nigeria’s NCDC has put the country on “high alert” after the DRC Ebola situation, urging enhanced surveillance and travel health declarations for arrivals from affected areas. Drug Deaths (Scotland): Scotland recorded drug-poisoning deaths rising 11% to 1,133 in 2025, with nitazenes implicated in 247 deaths and cocaine involved in over half of fatalities—again the worst rate in Europe. Workforce & Migration (Germany): Germany is easing permanent-residence rules for foreign graduates, allowing settlement after two years of qualified employment to help tackle labour shortages. AI & Health Data (Life Sciences): A new industry focus is emerging on AI adoption in biopharma, with clinical data harmonisation and EU AI Act compliance highlighted as key to turning tools into real outcomes. Maternal Health (Nigeria): The Gates Foundation and MTN launched an AI maternal-health platform aiming to reach 500,000 women by 2030. Nutrition & Heart Risk: A large review links higher ultra-processed food intake to greater cardiovascular events and metabolic risks, reinforcing the push for healthier everyday diets. Clinical Trials (Lung Cancer): MAIA Biotechnology won approvals to screen patients for its Phase 3 THIO-104 NSCLC trial in Spain and Portugal.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
